Savera Industrie (512634)

Score breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• ROE of 19.33% and ROCE of 17.18% indicate efficient capital use and solid underlying profitability.
• Sales grew 40.85% and profit 37.13%, with PEG of 0.33 suggesting the market is not fully pricing the growth.
• Piotroski F-score of 7/9 points to improving fundamentals and operational discipline.
• P/E of 12.93 and dividend yield of 1.97% provide a margin of safety and some income while waiting.

Concerns

• Hotel industry is cyclical and capital-intensive; current growth may reflect an upcycle rather than a durable moat.
• Latest quarter net margin is thin at roughly 11% (₹3 Cr profit on ₹27 Cr sales), leaving little room for cost pressure.
• Debt/Equity and promoter holding are not disclosed, limiting ability to assess financial risk and management alignment.
• Price is down from ₹189 high and near ₹133 low, showing earnings sensitivity to the cycle.

AI Analysis

At first glance, Savera Industrie looks like the kind of small-cap compounder I enjoy studying. A 12.93 price-to-earnings ratio combined with 37% profit growth and a 0.33 PEG is a rare combination. But I have to remind myself that hotels are not selling razors. This is a cyclical business where today's occupancy boom can become tomorrow's rate war. The 40.85% sales growth is impressive, but I need to ask how much of it is sustainable demand versus the upswing of the hotel cycle. The financial metrics are better than most in this industry. Return on equity of 19.33% and ROCE of 17.18% suggest management is creating value. The Piotroski F-score of 7 out of 9 reinforces that the fundamentals are improving. A dividend yield of nearly 2% gives me a little income while I wait. With book value of ₹65.58 and a price of ₹143.90, I am paying 2.19 times book — not cheap in absolute terms, but reasonable if the growth persists. Still, I would not call this a business with a wide moat. Hotels face intense competition, high fixed costs, and constant capex to keep rooms and facilities relevant. The lack of debt/equity data and promoter holding information is a yellow flag; I cannot fully assess financial risk or alignment. The latest quarter's margin is thin: ₹27 crore sales produced only ₹3 crore net profit. At ₹176 crore market cap, the market is pricing in continued improvement. I'd want to see several quarters of discipline before calling it a true Buffett-style compounder. For now, it is a well-run cyclical on an attractive valuation.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer